Analysts Viewpoint Investing in LENZ Therapeutics Inc (LENZ) Is Getting More Attractive LENZ Therapeutics Inc’s recent filing unveils that its 10% Owner Versant Venture Capital VI, L. unloaded Company’s shares for reported